Shalini Rajaram

Shalini Rajaram

Auto-generated profile, based on publicly available information

Shalini Rajaram

Department of Obstetrics and Gynecology (Gynecologic Oncology), All India Institute of Medical Sciences, Rishikesh, India

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Best Practice & Research Clinical Obstetrics & Gynaecology
Verified
Journal Article
Closed access
SRShalini Rajaram
Shalini Rajaram
AMAmita Maheshwari
Amita Maheshwari
ASAstha Srivastava
Astha Srivastava

1 March 2019 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Closed access
RBRupsa C Boelig
Rupsa C Boelig
Luigi Della CorteLuigi Della Corte
Luigi Della Corte
SASherif Ashoush
Sherif Ashoush
DMDavid McKenna
David McKenna
GSGabriele Saccone
Gabriele Saccone
VBVincenzo Berghella
Vincenzo Berghella

1 January 2017 in Indian Journal of Community Medicine
Verified
Journal Article
Open access
PDF file
ASAnshuja Singla
Anshuja Singla
SRShalini Rajaram
Shalini Rajaram
SMSumita Mehta
Sumita Mehta
GRGita Radhakrishnan
Gita Radhakrishnan
Objective: To assess various causes of maternal mortality over a ten year period Design: Retrospective audit of hospital case records Setting: Tertiary care hospital Population: Pregnant women who expired in the premises of GTB Hospital. Materials and Methods: A retrospective audit of case records of maternal deaths was conducted for a ten year period (January 2005 to December 2014). Results: There were a total of 647 maternal deaths out of 1,16,641 live births. Sixty-eight percent (n = 445) of women were aged 21-30 years, while 10.5% (n = 68) were <20 years of age. The most common direct causes of maternal mortality were preeclampsia/eclampsia in 24.4% (n = 158), obstetric hemorrhage in 19.1% (n = 124) and puerperal sepsis in 14.5% (n = 94). With regards to indirect causes, anemia accounted for 15.3% (n = 99) mortality. There was only 1 (0.1%) mortality because of HIV/AIDS. Other notable causes of maternal mortality were infective hepatitis in 7.1% (n = 46). Tuberculosis, that is a disease of tropical countries, accounted for 3.0% (n = 20) of the total deaths. Conclusion: High maternal mortality in GTB hospital can be due to it being a tertiary hospital with referrals from all neighbouring states. Accessible antenatal care can help prevent these maternal deaths. Female education can be of immense help in dealing with the problem and improving the utilization of public health facilities.

1 December 2023 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
RRRakhi Rai
Rakhi Rai
RSRohini Sehgal
Rohini Sehgal
SSSeema Singhal
Seema Singhal
VSVanita Suri
Vanita Suri
PSPoonam Shivkumar
Poonam Shivkumar
NBNeerja Bhatla
Neerja Bhatla
Objectives: The 70% screening coverage target proposed in the global cervical cancer elimination strategy is not achieved even at tertiary centres in India. A situational analysis was done to assess the currently existing facilities and barriers in tertiary care institutes. Methods: This cross sectional multicentric study was conducted from August to September 2021 in six tertiary care institutes across India. Women aged 30-49 years attending outpatient services (OPD) were invited for cervical screening. Women and health care professionals (HCPs) were administered structured questionnaires to assess knowledge, attitude and practices regarding cervical cancer screening services. Results: Out of 6709 eligible women who attended OPD, 1666 (24.8%; range:19-57%) received screening. Availability of screening kits was limited to 10-25 Pap/HPV tests per day. Visual inspection with acetic acid (VIA) and HPV testing were offered only at certain centres. Colposcopy and treatment facilities were optimal at all centres. Knowledge, attitude and practices were analysed for 1800 women: 45.7% had heard of cervical cancer, 78.0% did not know that it is preventable, 75.8% never heard about screening. Common symptoms correctly identified included postmenopausal bleeding (4.8%), postcoital bleeding (5.7%), intermenstrual bleeding (5.8%) and vaginal discharge (12.4%). Risk factors were identified by minority: poor menstrual hygiene (6.6%), oral contraceptive pill use (6.4%), multiparity (4.4%), and HPV infection (3.0%). Out of 21, mean total knowledge score (MTKS) was 2.07± 2.67. Out of 317 HCPs, 96.5% knew that cervical cancer is caused by HPV infection, is preceded by premalignant stage, and that it is preventable by screening and treatment (80.1%). Knowledge about screening modalities was present in 87.4% for cytology, 75.1% for VIA, 68.8% for HPV test. MTKS of HCPs was 20.88±6.61 out of 32. Conclusion: Even at tertiary centres, limited availability of HPV tests, reluctance to implement VIA and lack of awareness among women remain the major barriers.

26 September 2024 in Indian Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MKMayank Kapoor
Mayank Kapoor
ASAnusha Mruthyunjaya Swamy
Anusha Mruthyunjaya Swamy
DSDeepak Sundriyal
Deepak Sundriyal
MKMridul Khanna
Mridul Khanna
NSNishant Sinha
Nishant Sinha
ASAmit Sehrawat
Amit Sehrawat

1 January 2010 in Journal of Cancer Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
SRS Rajaram
S Rajaram
HSH Sharma
H Sharma
SBSk Bhargava
Sk Bhargava
RTRp Tripathi
Rp Tripathi
NGN Goel
N Goel
SMS Mehta
S Mehta
Aims: (1) To map the extent of disease in women with stage I and II carcinoma cervix by multislice spiral computed tomography (CT), magnetic resonance imaging (MRI) and sentinel nodes. (2) To assess accuracy of each modality individually and in conjunction with FIGO clinical staging. Design and Setting: Prospective, single-blind study. Departments of Obstetrics and Gynaecology, Radiodiagnosis, and Pathology, UCMS and GTBH and Division of Radiological Imaging and Bioinformatics, INMAS, Delhi. Material and Method: The study was conducted on 25 women with cervical cancer FIGO stage I and II. Each woman underwent clinical staging, multislice spiral CT and MRI which was compared to the gold-standard histopathology/cytology. The overall accuracy of each modality and improvement of clinical staging by CT/MRI were noted. Sentinel nodes were evaluated by intracervical Patent Blue V dye injection. Statistical Analysis: Sensitivity, specificity, positive and negative predictive values were calculated by 2Χ2 contingency tables. Results: The accuracy of staging by FIGO, CT and MRI was 68%, 52% and 80%, respectively. MRI and CT improved the overall accuracy of FIGO staging to 96% and 80%, respectively. Sentinel nodes were identified in 89% of patients with 91% accuracy. Conclusion: MRI emerges as the most valuable stand-alone modality improving accuracy of FIGO staging to 96%. Sentinel lymph-node evaluation appears promising in evaluating spread beyond cervix.